TOXICOLOGICAL AND PHARMACOLOGICAL STUDIES ON 9-HYDROXY-ELLIPTICINE IN MICE

[1] BESSIS M, 1954, TRAITE CYTOLOGIE SAN

[2] CHANH PH, 1974, CR ACAD SCI D NAT, V279, P1039

[3] CONNEY AH, 1967, PHARMACOL REV, V19, P317

[4] SYNTHESIS OF TUMOUR-INHIBITORY ALKALOIDS ELLIPTICINE 9-METHOXYELLIPTICINE AND RELATED PYRIDO[4,3-B]CARBAZOLES [J]. AUSTRALIAN JOURNAL OF CHEMISTRY, 1967, 20 (12) : 2715 - &

[5] DUBOST M, 1964, CANCER CHEMOTH REP, P35

[6] NEW DNA INTERCALATING DRUG - METHOXY-9-ELLIPTICINE [J]. FEBS LETTERS, 1971, 17 (02): : 321 - +

[7] FONDY TP, 1974, CANCER CHEMOTH REP 1, V58, P317

[8] FREIREICH EMIL J., 1966, CANCER CHEMOTHERAP REP, V50, P219

[9] Ganter P., 1969, HISTOCHIMIE NORMALE, VVolume 1

[10] GRIMM H, 1973, BIOSTATISTICS PHARMA, V2, P675

[1] BESSIS M, 1954, TRAITE CYTOLOGIE SAN

[2] CHANH PH, 1974, CR ACAD SCI D NAT, V279, P1039

[3] CONNEY AH, 1967, PHARMACOL REV, V19, P317

[4] SYNTHESIS OF TUMOUR-INHIBITORY ALKALOIDS ELLIPTICINE 9-METHOXYELLIPTICINE AND RELATED PYRIDO[4,3-B]CARBAZOLES [J]. AUSTRALIAN JOURNAL OF CHEMISTRY, 1967, 20 (12) : 2715 - &

[5] DUBOST M, 1964, CANCER CHEMOTH REP, P35

[6] NEW DNA INTERCALATING DRUG - METHOXY-9-ELLIPTICINE [J]. FEBS LETTERS, 1971, 17 (02): : 321 - +

[7] FONDY TP, 1974, CANCER CHEMOTH REP 1, V58, P317

[8] FREIREICH EMIL J., 1966, CANCER CHEMOTHERAP REP, V50, P219

[9] Ganter P., 1969, HISTOCHIMIE NORMALE, VVolume 1

[10] GRIMM H, 1973, BIOSTATISTICS PHARMA, V2, P675